This is our top methylfolate pick, and it is honest about what that means. Solgar uses Metafolin, a bioidentical L-5-MTHF that needs no enzymatic conversion, at 400 mcg (666 mcg DFE) — the right dose. For someone with a documented MTHFR variant or a preference to bypass conversion, it is a sensible, clean option from a trusted brand. But note the ranking: it sits below every folic acid pick because methylfolate has no NTD-prevention trial evidence. It raises blood folate as well as folic acid does; it has simply never been tested against the outcome that matters for pregnancy. Pay the premium only if you have a specific reason to.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Folate guide →L-methylfolate raises folate status effectively but has no randomized NTD-prevention trials — the evidence gap versus folic acid is real and drives this ranking.
Metafolin is bioidentical L-5-MTHF, absorbed directly with no conversion step — genuinely useful for those with reduced MTHFR enzyme activity.
400 mcg (666 mcg DFE) is exactly on the prenatal target — a well-judged dose, unlike the 1 mg options.
Non-GMO, vegan, kosher and gluten-free, but no independent USP audit.
Around $20 for 100 tablets — reasonable within the methylfolate category, but several times the cost-per-dose of folic acid.
“Methylfolate needs no conversion so it's better for MTHFR carriers”
L-5-MTHF bypasses the MTHFR-dependent conversion step and raises folate as effectively as folic acid even in 677TT women (Prinz-Langenohl 2009, PMID 19298256), but this benefit is meaningful mainly for those with a confirmed variant.
“Methylfolate prevents neural-tube defects as well as folic acid”
No randomized trial has tested methylfolate for NTD prevention. Reviews note folic acid remains the form with proven periconceptional benefit (Obeid 2013, PMID 23482308).
For a woman with a documented MTHFR 677TT genotype or established methylation concerns, Metafolin is a rational choice. For everyone else it solves a problem they likely do not have.
Studies show methylfolate matches folic acid at raising blood folate — but 'raises folate levels' and 'prevents birth defects' are different endpoints. Only folic acid has the second.
This is the methylfolate to choose if you genuinely need methylfolate — a confirmed MTHFR variant, a clinician's direction, or documented intolerance to folic acid. It is well-formulated and correctly dosed. But it ranks below the folic acid picks because the NTD evidence lives with folic acid, and paying five times more for an unproven-for-that-outcome form is not the smart default.
Check Solgar on Amazon5-MTHF raised plasma folate at least as effectively as folic acid, including in 677TT women.
Concludes 5-MTHF is a plausible but unproven alternative; folic acid retains the trial evidence for NTD prevention.
